Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials.

MLA

Griffiths, Christopher, et al. “Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials.” Dermatology & Therapy, vol. 11, no. 4, Aug. 2021, pp. 1357–72. EBSCOhost, https://doi.org/10.1007/s13555-021-00558-0.

APA

Griffiths, C., de Bruin-Weller, M., Deleuran, M., Fargnoli, M. C., Staumont-Sallé, D., Hong, C., Sánchez-Carazo, J., Foley, P., Seo, S. J., Msihid, J., Chen, Z., Cyr, S. L., & Rossi, A. B. (2021). Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials. Dermatology & Therapy, 11(4), 1357–1372. https://doi.org/10.1007/s13555-021-00558-0

Chicago

Griffiths, Christopher, Marjolein de Bruin-Weller, Mette Deleuran, Maria Concetta Fargnoli, Delphine Staumont-Sallé, Chih-ho Hong, Jose Sánchez-Carazo, et al. 2021. “Dupilumab in Adults with Moderate-to-Severe Atopic Dermatitis and Prior Use of Systemic Non-Steroidal Immunosuppressants: Analysis of Four Phase 3 Trials.” Dermatology & Therapy 11 (4): 1357–72. doi:10.1007/s13555-021-00558-0.